When liver enzyme dynamics during pre-NAFLD stage were evaluated, AST, ALT, and GGT all increased in group 2 during the first period (2009–2011) with statistical significance in men, but not in women. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.